Our results reveal a necessary mechanism through which obesity medications d-fenfluramine and sibutramine achieve their therapeutic appetitive effect, via activation of ARC POMC neurons. This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.